The Class 12 Biology sample paper covers topics like competition, recombinant DNA technology, immunity, and population ...

The global molecular cloning market size is calculated at USD 5.53 billion in 2025 and is expected to reach around USD 8.89 billion by 2034, growing at a CAGR of 5.4% for the forecasted period.Ottawa, ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major ...

Good evening, and welcome to Dyadic International's Q3 2025 Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, November 12, 2025. I would now like to ...

The monoclonal antibodies in veterinary health market size reached US$ 1.45 billion in 2025 and is anticipate to increase to ...

CompletedstrategicpivotfromR&Dfocustocommercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize ...

In a significant regulatory move, the Ministry of Health and Family Welfare (MoHFW) has proposed amendments to the Drugs Rules, 1945, to expand the scope of India's biotechnology ...

This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping overcome manufacturing bottlenecks in gene therapy.

Dr. Watson was one of three recipients of the 1962 Nobel Prize in Physiology or Medicine for decoding the genetic blueprint for life.

Sepsis is one of the most frequent causes of death worldwide, claiming nearly 11 million lives, accounting for 20% of all global deaths [1, 2] and taking more lives than cancer [3]. This is more than ...